Literature DB >> 34823649

Treatment outcomes among rural and urban patients with obstructive sleep apnea: a prospective cohort study.

Jennifer Corrigan1, Willis H Tsai1,2, Ada Ip-Buting3, Christopher Ng4, Imhokhai Ogah5, Peter Peller6, Heather Sharpe1,7, Cheryl Laratta7, Sachin R Pendharkar1,2.   

Abstract

STUDY
OBJECTIVES: To determine whether adherence to continuous positive airway pressure (CPAP) in adults with uncomplicated obstructive sleep apnea differs by rural vs urban residential address.
METHODS: In this prospective cohort study, we recruited adults who initiated CPAP for uncomplicated obstructive sleep apnea that was diagnosed by a physician using sleep specialist-interpreted diagnostic testing. Participants were classified as urban (community size > 100,000) or rural (community size < 100,000) by translating residential postal code into geographic census area. The primary outcome was mean daily hours of CPAP use compared between rural and urban patients. Secondary outcomes included the proportion of patients who were adherent to CPAP, change in Epworth Sleepiness Scale score, change in EuroQOL-5D visual analog score, and Visit-Specific Satisfaction Instrument score. All outcomes were measured 3 months after CPAP initiation.
RESULTS: We enrolled 242 patients (100 rural) with a mean (standard deviation) age of 51 (13) years and a respiratory event index of 24 (18) events/h. The mean (95% confidence interval) CPAP use was 3.19 (2.8-3.58) hours/night and 35% were CPAP-adherent, with no difference between urban and rural patients. Among the 65% of patients who were using CPAP at 3 months, the mean CPAP use was 4.89 (4.51-5.28) hours/night and was not different between rural and urban patients. Improvement in the Epworth Sleepiness Scale score and patient satisfaction was similar between groups, but the EuroQOL-5D score improved to a greater extent in rural patients. Urban or rural residence was not associated with CPAP adherence according to multivariable regression analysis.
CONCLUSIONS: Rural vs urban residence was not associated with differences in CPAP adherence among patients with uncomplicated OSA diagnosed by a physician using specialist-interpreted sleep diagnostic testing. CITATION: Corrigan J, Tsai WH, Ip-Buting A, et al. Treatment outcomes among rural and urban patients with obstructive sleep apnea: a prospective cohort study. J Clin Sleep Med. 2022;18(4):1013-1020.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  continuous positive airway pressure; geographic factors; obstructive sleep apnea; rural health; treatment outcome

Mesh:

Year:  2022        PMID: 34823649      PMCID: PMC8974366          DOI: 10.5664/jcsm.9776

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  37 in total

1.  The economic cost of inadequate sleep.

Authors:  David Hillman; Scott Mitchell; Jared Streatfeild; Chloe Burns; Dorothy Bruck; Lynne Pezzullo
Journal:  Sleep       Date:  2018-08-01       Impact factor: 5.849

2.  Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

3.  A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.

Authors:  Jamey J Lister; Addie Weaver; Jennifer D Ellis; Joseph A Himle; David M Ledgerwood
Journal:  Am J Drug Alcohol Abuse       Date:  2019-12-06       Impact factor: 3.829

4.  Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system.

Authors:  John-Michael Gamble; Dean T Eurich; Justin A Ezekowitz; Padma Kaul; Hude Quan; Finlay A McAlister
Journal:  Circ Heart Fail       Date:  2011-03-23       Impact factor: 8.790

5.  Primary care vs specialist sleep center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial.

Authors:  Ching Li Chai-Coetzer; Nick A Antic; L Sharn Rowland; Richard L Reed; Adrian Esterman; Peter G Catcheside; Simon Eckermann; Norman Vowles; Helena Williams; Sandra Dunn; R Doug McEvoy
Journal:  JAMA       Date:  2013-03-13       Impact factor: 56.272

6.  Relationship between Travel Time from Home to a Regional Sleep Apnea Clinic in British Columbia, Canada, and the Severity of Obstructive Sleep.

Authors:  A J M Hirsch Allen; Ofer Amram; Hamid Tavakoli; Fernanda R Almeida; Mona Hamoda; Najib T Ayas
Journal:  Ann Am Thorac Soc       Date:  2016-05

7.  Continuity of care for patients with chronic conditions from rural or remote Australia: A systematic review.

Authors:  Tamara D Street; Klaire Somoray; Georgia C Richards; Sarah J Lacey
Journal:  Aust J Rural Health       Date:  2019-05-10       Impact factor: 1.662

8.  Distance to Specialist Medical Care and Diagnosis of Obstructive Sleep Apnea in Rural Saskatchewan.

Authors:  Catherine M Spagnuolo; Michael McIsaac; James Dosman; Chandima Karunanayake; Punam Pahwa; William Pickett
Journal:  Can Respir J       Date:  2019-01-14       Impact factor: 2.409

9.  Positive airway pressure therapy supplied by an integrated sleep practice associated with greater adherence among pre-Medicare-aged patients with sleep-disordered breathing.

Authors:  James M Andry; Gabriel Toban; Cynthia Chafin; William Noah
Journal:  J Clin Sleep Med       Date:  2021-01-01       Impact factor: 4.062

10.  Integrated diagnostic pathway for patients referred with suspected OSA: a model for collaboration across the primary-secondary care interface.

Authors:  Nikesh Devani; Tom Aslan; Fiona Leske; Stephanie K Mansell; Sarah Morgan; Swapna Mandal
Journal:  BMJ Open Respir Res       Date:  2020-11
View more
  1 in total

1.  Rural residence and adherence to continuous positive airway pressure therapy: have we overcome a barrier?

Authors:  Lucas M Donovan
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.324

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.